share_log

啓明醫療-B:2023年度報告

VENUS MEDTECH-B: 2023 ANNUAL REPORT

Hong Kong Stock Exchange ·  Apr 29 21:00
Summary by Futu AI
董事會於2023年12月31日年度結束時,提出了公司治理報告。報告顯示,公司遵守了《公司治理守則》的守則條款,唯獨D.1.2條款除外。該年度共召開五次股東大會,所有提案均獲通過。董事會由八名董事組成,職責分明,並舉行了十次會議以審議各項公司事務。設有三個董事會委員會:審計、薪酬評估及提名委員會,每個委員會年內各開會兩次以履行職責。高級管理層的薪酬按薪資級別披露。持有10%或以上投票權的股東可要求召開股東特別大會。公司採納了針對董事及監事進行證券交易的行為守則。審計委員會審閱了截至2023年12月31日的綜合財務報表。公司建立了內部控制系統,並進行年度效能評估。董事會根據財務表現和現金流等因素提...展開全部
董事會於2023年12月31日年度結束時,提出了公司治理報告。報告顯示,公司遵守了《公司治理守則》的守則條款,唯獨D.1.2條款除外。該年度共召開五次股東大會,所有提案均獲通過。董事會由八名董事組成,職責分明,並舉行了十次會議以審議各項公司事務。設有三個董事會委員會:審計、薪酬評估及提名委員會,每個委員會年內各開會兩次以履行職責。高級管理層的薪酬按薪資級別披露。持有10%或以上投票權的股東可要求召開股東特別大會。公司採納了針對董事及監事進行證券交易的行為守則。審計委員會審閱了截至2023年12月31日的綜合財務報表。公司建立了內部控制系統,並進行年度效能評估。董事會根據財務表現和現金流等因素提出分紅建議。報告期內,公司未進行任何上市證券的購買、出售或贖回。公司設有透明的董事提名政策,由提名委員會負責向董事會推薦合適的候選人。公司維持強大的企業文化,以實現長期可持續績效並履行企業公民責任。2023年度綜合財務報表已按照香港審計準則進行審計。該公司治理報告已包含在截至2023年12月31日的年度報告中。
The Board of Directors submitted a Corporate Governance Report at the end of the year ended 31 December 2023. The report showed that the company complied with the Code of Conduct provisions of the Corporate Governance Code, with the sole exception of clause D.1.2. A total of five general meetings were held that year, and all proposals were approved. The Board of Directors consists of eight directors with clear responsibilities and holds ten meetings to review the company's affairs. THERE ARE THREE BOARD COMMITTEES: AUDIT, REMUNERATION EVALUATION AND NOMINATING COMMITTEES. EACH COMMITTEE MEETS TWICE A YEAR TO FULFILL ITS DUTIES. Disclosure of remuneration by salary level for senior management. Shareholders with voting rights of 10% or more may request the convening of...Show More
The Board of Directors submitted a Corporate Governance Report at the end of the year ended 31 December 2023. The report showed that the company complied with the Code of Conduct provisions of the Corporate Governance Code, with the sole exception of clause D.1.2. A total of five general meetings were held that year, and all proposals were approved. The Board of Directors consists of eight directors with clear responsibilities and holds ten meetings to review the company's affairs. THERE ARE THREE BOARD COMMITTEES: AUDIT, REMUNERATION EVALUATION AND NOMINATING COMMITTEES. EACH COMMITTEE MEETS TWICE A YEAR TO FULFILL ITS DUTIES. Disclosure of remuneration by salary level for senior management. Shareholders with voting rights of 10% or more may request the convening of a special general meeting. The Company has adopted a Code of Conduct for Securities Transactions for Directors and Supervisors. The Audit Committee reviewed the consolidated financial statements for the year ended 31 December 2023. The company establishes an internal control system and conducts annual performance evaluations. The Board of Directors proposes a dividend based on factors such as financial performance and cash flow. During the reporting period, the Company did not purchase, sell or redeem any listed securities. The company has a transparent director nomination policy, and the Nomination Committee is responsible for recommending suitable candidates to the Board of Directors. The company maintains a strong corporate culture to achieve long-term sustainable performance and fulfill its corporate citizenship responsibilities. THE CONSOLIDATED FINANCIAL STATEMENTS FOR 2023 HAVE BEEN AUDITED IN ACCORDANCE WITH THE HONG KONG AUDIT CRITERIA. The Corporate Governance Report has been included in the Annual Report as of 31 December 2023.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.